Tuesday, April 28, 2020

Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice

Exenatide is an insulinotropic peptide drug for type 2 diabetes treatment with low risk of hypoglycemia, and is administrated by subcutaneous injection. Oral administration is the most preferred route for life...

from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/2Ye6aSU
via IFTTT

No comments:

Post a Comment